Abstract
Aims: To investigate the factors of postoperative malignant brain edema (MBE) in patients with acute ischemic stroke (AIS) treated with endovascular treatment (EVT).
Background: MBE is a severe complication following EVT for AIS, and it is essential to identify risk factors early. Peripheral arterial lactate (PAL) levels may serve as a potential predictive marker for MBE.
Objective: To determine whether immediate postoperative PAL levels and the highest PAL level within 24 hours of EVT are independently associated with MBE development in AIS patients.
Methods: We retrospectively analyzed patients with AIS who underwent EVT from October 2019 to October 2022. Arterial blood was collected every 8 h after EVT to measure PAL, and record the immediate postoperative PAL and the highest PAL level within 24 h. Brain edema was evaluated using brain computed tomography scans within 7 days of EVT.
Results: The study included 227 patients with a median age of 71 years, of whom 59.5% were male and MBE developed in 25.6% of patients (58/227). Multivariate logistic regression analysis showed that the immediate postoperative PAL (odds ratio, 1.809 [95% confidence interval (CI), 1.215-2.693]; p = 0.004) and the highest PAL level within 24 h of EVT (odds ratio, 2.259 [95% CI, 1.407-3.629]; p = 0.001) were independently associated with MBE. The area under the curve for predicting MBE based on the highest PAL level within 24 hours of EVT was 0.780 (95% CI, 0.711-0.849).
Conclusion: Early increase in PAL levels is an independent predictor of MBE after EVT in AIS patients.
[PMID: 36207112]
[http://dx.doi.org/10.3988/jcn.2022.18.3.298] [PMID: 35196752]
[http://dx.doi.org/10.1161/STR.0000000000000211] [PMID: 31662037]
[http://dx.doi.org/10.1161/STROKEAHA.118.022001] [PMID: 30571414]
[http://dx.doi.org/10.1016/j.jns.2019.116607] [PMID: 31830611]
[http://dx.doi.org/10.1136/neurintsurg-2018-014650] [PMID: 30798266]
[http://dx.doi.org/10.1097/ANA.0000000000000584] [PMID: 31116707]
[http://dx.doi.org/10.3390/metabo9110245] [PMID: 31652842]
[http://dx.doi.org/10.1161/01.STR.0000083624.74929.32] [PMID: 12881606]
[http://dx.doi.org/10.1161/01.STR.32.8.1863] [PMID: 11486118]
[http://dx.doi.org/10.3171/jns.1988.69.5.0736] [PMID: 3183734]
[http://dx.doi.org/10.1097/ANA.0000000000000582] [PMID: 30893283]
[http://dx.doi.org/10.1016/j.braindev.2011.08.004] [PMID: 21875773]
[http://dx.doi.org/10.3174/ajnr.A2985] [PMID: 22383238]
[http://dx.doi.org/10.1001/jamaneurol.2017.5162] [PMID: 29365017]
[http://dx.doi.org/10.1007/s00134-015-4127-0] [PMID: 26556617]
[http://dx.doi.org/10.1161/STROKEAHA.113.004475] [PMID: 24643407]
[http://dx.doi.org/10.1016/j.expneurol.2009.03.035] [PMID: 19348795]
[http://dx.doi.org/10.3389/fneur.2022.1077043] [PMID: 36619912]
[http://dx.doi.org/10.1136/practneurol-2019-002191] [PMID: 32404406]
[http://dx.doi.org/10.1152/physrev.00062.2017] [PMID: 30565508]
[http://dx.doi.org/10.1016/j.neuint.2010.06.012] [PMID: 20600436]
[http://dx.doi.org/10.1093/infdis/166.3.546] [PMID: 1500738]
[http://dx.doi.org/10.3389/fncel.2021.716825] [PMID: 34483842]
[http://dx.doi.org/10.1002/med.20064] [PMID: 16758487]